← All stocks

Johnson & Johnson

JNJPharmaceuticalsLatest filing used: 2026-10-21Filings on SEC EDGAR ↗

Above fair value Dividend grower Flags raised

Fair value per share

$99.76

from SEC filings only

Last close

$285.96

Nov 13, 2026

186.7% above fair value

Margin of safety price
$74.82
25% below fair value
Stress case
$61.29
if things go badly

Its filings point to about $99.76 a share, most likely between $78.30 and $130.35.

Where it sits

127 of the 653 stocks we value that have a close are even further above their estimates.

Counts the 653 stocks that have both a value and a close as of Nov 13. Positions are squeezed so the biggest gaps fit.

The short case

In favour

  • It turns about 19% of its sales into cash in a typical year.
  • It earns high returns on the money invested in it.
  • Its debt is modest next to its equity.

Against

  • Its last close is about 187% above what its filings say it is worth.
  • Years in which the company sold or closed a business are left out of the record.
  • Growth is measured on the latest annual report's restated figures, because earlier years include businesses since sold or closed.

Written automatically from the filings, by the same rules for every company. Not a recommendation.

Price tags

The last close next to our fair value, the filings-based estimate above. Profit and cash flow: the 12 months to September 27, 2026.

MeasureAt last close$285.96Nov 13At our fair value$99.76
Market valueAll 2.4 billion shares at that price (the diluted count, which includes stock options and awards)$700.2B$244.3B
Price / earnings (P/E)Dollars paid for each $1 of yearly profit43.5×15.2×
Price / free cash flowDollars paid for each $1 of cash left each year after paying for equipment34.0×11.9×
EV / EBITDAPrice of the whole business (shares plus debt, less cash) for each $1 of yearly profit before interest, tax and wear and tearNot shown: we couldn't find every number this needs in the filings.Not shown: we couldn't find every number this needs in the filings.

Our own arithmetic on the filings, the last close and our fair value, which is an estimate. One unusual year can push any of these very high or very low. How we work these out

Five areas

18 of 25 checks passedStrong in 2 of 5 areas

GrowthFair · 3 of 5
  • Revenue up 5%+ a year over 3 years (passed)
  • Revenue up 5%+ a year over 5 years (not passed)
  • Earnings per share up 5%+ a year over 5 years (passed)
  • Revenue up over the last 12 months (passed)
  • Earnings per share up over the last 12 months (not passed)
ProfitabilityFair · 3 of 5
  • Return on equity of 15%+ (last 12 months) (passed)
  • Return on equity of 12%+ (5-year average) (passed)
  • Return on invested capital of 10%+ (5-year average) (passed)
  • Operating margin of 10%+ (5-year average) (no data)
  • Operating margin holding up (last 12 months vs 5 years) (no data)
Cash generationStrong · 5 of 5
  • Cash earnings positive in almost every year (at most one bad year) (passed)
  • Typical year turns 10%+ of revenue into cash (passed)
  • Latest year at or above the typical year (passed)
  • Free cash flow positive (last 12 months) (passed)
  • Revenue larger than 5 years ago (passed)
Balance sheetFair · 3 of 5
  • Debt no larger than equity (passed)
  • Cash and short-term investments exceed debt (not passed)
  • Positive shareholders' equity (passed)
  • Debt clearly tagged in the filings (passed)
  • Operating margin above zero (last 12 months) (no data)
Shareholder returnsStrong · 4 of 5
  • Pays a dividend (passed)
  • Dividend paid in each of the last 5 years (passed)
  • Dividend grew over 5 years (passed)
  • Pays out 75% or less of earnings (not passed)
  • Share count flat or falling over 5 years (passed)

Flags

Years in which the company sold or closed a business are left out of the record.

Growth is measured on the latest annual report's restated figures, because earlier years include businesses since sold or closed.

How we got this number

In a typical year JNJ kept 20% of its revenue as cash after running and maintaining the business (before interest). We assume revenue grows 5.2% a year for five years, then slows to 2.5% by year ten, and discount the cash at 9.4% a year (the 10-year Treasury yield plus 5 points, blended with the cost of its debt). That is worth $99.76 a share today.

Technical details
Model
Discounted cash flow on cash earnings
Cash-earnings margin: typical year (worst / best 3-year stretch)
19.9% (18.5% / 21.6%)
Years used
2017–2025
Revenue growth, years 1–5 (range tested)
5.2% (0 to 10%)
Capital needed per $1 of new revenue
$0.22 equipment, $0.09 working capital
Discount rate
9.4%
Revenue base
$94.2B (lower of TTM and last FY)
Debt / cash
$44.7B / $17.2B
Value if investors require Treasury + 3 / + 8 points (we use + 5)
$125.62 / $76.12
If growth after year 10 keeps today's returns
$116.27
Likely range
10th–90th percentile of 4,000 runs with different assumptions
Required return
10-year Treasury 5.15% (2026-11-13) + 5%

What the price assumes

For our model to reach the last close of $285.96 (Nov 13, 2026), JNJ would have to keep 52¢ of every $1 of sales as cash. Its best year was 22¢ and a typical year 20¢.

What the price needs
52¢
Its typical year
20¢
Its last 3 years checked (2021, 2024, 2025)
20¢
Its best year
22¢

So the price is betting on more than we assume: a higher margin than in any of the 7 years we checked, faster or longer growth than our rules allow, a discount rate below our 9.4%, or something our model leaves out. Our growth rules are cautious: growth is capped at 15% a year and adds no value after year 10.

Typical, best and worst years are from the 7 years we checked in its filings, between 2017 and 2025 (years that include businesses it has since sold, spun off, closed or put up for sale are left out). Everything else stays as described above, including the growth path and the discount rate.

Technical details

Value per share is a straight line in the margin until it reaches zero: value = margin × cash factor − (growth spending + debt and other claims) per share. We solve for the margin that gives the last close, with growth, discount rate, equipment and working capital held as in the main model.

Revenue base $94.2B. Growth 5.2% for five years, fading to 2.5% by year 10. Discount rate 9.4%. At 19.9¢ the filings-based value is $99.76. Each extra 1¢ of margin adds $5.80 a share. The last close is $285.96, which is $186.20 above the filings-based value, so the margin would have to rise by 32.1¢, to 52.0¢.

Terminal rule: Growth after year 10 earns only the discount rate, so it adds no value.

Ten years of results

Revenue

$94.2B in FY2025, up 6% on the year before

FY2017: $71.9BFY2017: $76.5BFY2018: $81.6BFY2019: $82.1BFY2021: $82.6BFY2022: $78.7BFY2023: $80.0BFY2023: $85.2BFY2024: $88.8BFY2025: $94.2B$50B$100BFY17FY19FY23FY25$94.2B
Show as table
YearRevenue
FY2017$71.9B
FY2017$76.5B
FY2018$81.6B
FY2019$82.1B
FY2021$82.6B
FY2022$78.7B
FY2023$80.0B
FY2023$85.2B
FY2024$88.8B
FY2025$94.2B

Cash earnings as a share of sales

21.2% of sales in FY2025

FY2017: 19.5%FY2017: 19.5%FY2018: 19.9%FY2019: 19.1%FY2021: 16.6%FY2024: 21.6%FY2025: 21.2%0%12%25%FY17FY19FY23FY2521%
Show as table
YearCash earnings as a share of sales
FY201719.5%
FY201719.5%
FY201819.9%
FY201919.1%
FY202116.6%
FY2022–
FY2023–
FY2023–
FY202421.6%
FY202521.2%

Dividends per share

$5.14 a share in FY2025

FY2017: $3.15FY2017: $3.32FY2018: $3.54FY2019: $3.75FY2021: $3.98FY2022: $4.19FY2023: $4.45FY2023: $4.70FY2024: $4.91FY2025: $5.14$3$6FY17FY19FY23FY25$5.14
Show as table
YearDividends per share
FY2017$3.15
FY2017$3.32
FY2018$3.54
FY2019$3.75
FY2021$3.98
FY2022$4.19
FY2023$4.45
FY2023$4.70
FY2024$4.91
FY2025$5.14

Shares outstanding

Share count fell 13% over 9 years

FY2017: 2.79BFY2017: 2.75BFY2018: 2.73BFY2019: 2.68BFY2021: 2.67BFY2022: 2.67BFY2023: 2.66BFY2023: 2.56BFY2024: 2.43BFY2025: 2.43B01.5B3BFY17FY19FY23FY252.43B
Show as table
YearShares outstanding
FY20172.79B
FY20172.75B
FY20182.73B
FY20192.68B
FY20212.67B
FY20222.67B
FY20232.66B
FY20232.56B
FY20242.43B
FY20252.43B

Delayed quote

Delayed price and chart from TradingView. This site does not receive or store these prices, and the fair value above does not use them. Showing the chart sends TradingView this page's address, the widget type, the ticker and your IP address, and TradingView may collect analytics; see Privacy.

Open on Yahoo Finance ↗

Sources. Company figures: SEC EDGAR (XBRL filings), latest filing used 2026-10-21. Interest rate: U.S. Treasury, 10-year par yield, 2026-11-13. Last close: IEX Historical Data, 2026-11-13. Price tags: our own arithmetic on the SEC figures, the last close and our fair value.